Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 73451-73500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06112808
A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin
PHASE1Active, not recruiting
300 participants
Started: May 29, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor30 locations
NCT05781854
Dexmedetomidine for Intermittent Epidural Boluses Versus Continuous Epidural Infusion for Labour Epidural Analgesia
PHASE2/PHASE3Recruiting
60 participants
Started: May 29, 2023 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT05224401
Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs
PHASE3Recruiting
330 participants
Started: May 29, 2023 · Completed: Sep 1, 2027
3 conditions1 sponsor5 locations
NCT05919979
Effect of a Physical Exercise Session Performed During a 24-34 Hour Fasting Period on Energy Metabolism and Cognitive Function in Healthy Adults
NARecruiting
20 participants
Started: May 29, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05809830
Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas
PHASE1/PHASE2Active, not recruiting
152 participants
Started: May 29, 2023 · Completed: May 8, 2026
1 condition1 sponsor6 locations
NCT05230199
Sensory Optimization of the Hospital Environment
NARecruiting
215 participants
Started: May 29, 2023 · Completed: Aug 31, 2027
5 conditions7 sponsors1 location
NCT06285370
A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy
PHASE4Active, not recruiting
23 participants
Started: May 29, 2023 · Completed: Nov 13, 2025
1 condition1 sponsor8 locations
NCT06737666
Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
PHASE1Recruiting
60 participants
Started: May 29, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06757257
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
N/ARecruiting
149 participants
Started: May 29, 2023 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT06403943
Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis
PHASE4Recruiting
292 participants
Started: May 29, 2023 · Completed: Dec 31, 2026
3 conditions13 sponsors1 location
NCT05860504
Acute Cardiac Dysfunction in Critical Illnes
N/ARecruiting
592 participants
Started: May 29, 2023 · Completed: Mar 30, 2026
6 conditions1 sponsor1 location
NCT06543680
Resin Modified Glass Ionomer Versus Self-Adhesive Resin Composite Restorative Systems
NARecruiting
35 participants
Started: May 29, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05846737
BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT
PHASE2Recruiting
20 participants
Started: May 29, 2023 · Completed: May 1, 2028
1 condition1 sponsor1 location
NCT05869812
Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes
PHASE2Recruiting
30 participants
Started: May 29, 2023 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT06075563
Total Lymphoid Irradiation as Conditioning for Pediatric Haploidentical Hematopoietic Stem Cell Transplantation
NARecruiting
23 participants
Started: May 29, 2023 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT06573671
Histiocytosis in Injecting Drug Users
N/AEnrolling by invitation
30 participants
Started: May 29, 2023 · Completed: Dec 31, 2030
1 condition5 sponsors1 location
NCT05706532
Cardiovascular and Cerebrovascular Control in Healthy Subjects
N/ARecruiting
60 participants
Started: May 29, 2023 · Completed: Oct 31, 2027
3 conditions1 sponsor1 location
NCT05809531
An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
PHASE3Active, not recruiting
100 participants
Started: May 29, 2023 · Completed: Jul 31, 2027
12 conditions1 sponsor47 locations
NCT06041893
Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide
N/ARecruiting
20 participants
Started: May 29, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06325111
Determinants of Glycaemic Control in Children With Type 1 Diabetes
N/ARecruiting
800 participants
Started: May 29, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05921695
The Relationship Between Normal Saline Infusion and Acute Kidney Injury in Heat Stroke
NARecruiting
190 participants
Started: May 28, 2023 · Completed: Mar 31, 2026
1 condition6 sponsors7 locations
NCT05921682
Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke
N/ARecruiting
100 participants
Started: May 28, 2023 · Completed: Mar 31, 2026
1 condition6 sponsors6 locations
NCT05923931
Non-inferiority Study of the Effect of Non-cooling Blanket on Body Temperature in Patients With Heat Stroke
NARecruiting
100 participants
Started: May 28, 2023 · Completed: Mar 31, 2026
1 condition7 sponsors7 locations
NCT05886114
A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China
NARecruiting
1,200 participants
Started: May 28, 2023 · Completed: Apr 28, 2027
10 conditions1 sponsor1 location
NCT06296160
A Simplified Lung Ultrasound Guided Management Protocol Of Pulmonary Congestion in Hemodialysis
NARecruiting
100 participants
Started: May 28, 2023 · Completed: May 22, 2024
1 condition2 sponsors1 location
NCT06191224
SwissGut - The Healthy Swiss Microbiome
N/ARecruiting
200 participants
Started: May 28, 2023 · Completed: Jul 5, 2025
1 condition1 sponsor1 location
NCT05811013
Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis
NARecruiting
40 participants
Started: May 27, 2023 · Completed: May 27, 2026
1 condition1 sponsor1 location
NCT05680805
Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS
PHASE4Active, not recruiting
100 participants
Started: May 27, 2023 · Completed: Nov 30, 2025
2 conditions2 sponsors1 location
NCT06496789
Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer
PHASE2Recruiting
35 participants
Started: May 27, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06443268
Cerebrovascular Disease: Quality of Life (CODE: QoL)
N/ARecruiting
680 participants
Started: May 27, 2023 · Completed: Jun 30, 2028
10 conditions1 sponsor1 location
NCT05664256
Evaluation of a Healthy Food Procurement Policy at Municipality-level in Nepal
NARecruiting
402 participants
Started: May 27, 2023 · Completed: Aug 30, 2024
1 condition2 sponsors1 location
NCT05608837
Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema
PHASE2Active, not recruiting
28 participants
Started: May 26, 2023 · Completed: Sep 30, 2026
2 conditions3 sponsors8 locations
NCT05898516
JoyPop Mobile Mental Health App With Indigenous Youth
NARecruiting
110 participants
Started: May 26, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05834881
Reducing Drug Use in Justice-Involved Emerging Adults
NARecruiting
80 participants
Started: May 26, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06116084
Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine
NARecruiting
100 participants
Started: May 26, 2023 · Completed: Apr 1, 2026
4 conditions1 sponsor1 location
NCT05825625
NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing
PHASE2Active, not recruiting
35 participants
Started: May 26, 2023 · Completed: Jun 1, 2027
1 condition3 sponsors2 locations
NCT05646082
Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma
PHASE1Recruiting
20 participants
Started: May 26, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05742217
A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases
N/ARecruiting
250 participants
Started: May 26, 2023 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT06055517
Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)
NARecruiting
29 participants
Started: May 26, 2023 · Completed: May 26, 2028
1 condition1 sponsor1 location
NCT05898555
Validation of Smart Garments for Gait Classification
N/ARecruiting
20 participants
Started: May 26, 2023 · Completed: Jun 30, 2024
1 condition2 sponsors1 location
NCT05851092
Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors
PHASE1Recruiting
60 participants
Started: May 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05671757
Daratumumab in Primary Antiphospholipid Syndrome
PHASE1/PHASE2Recruiting
22 participants
Started: May 26, 2023 · Completed: Mar 31, 2027
1 condition4 sponsors8 locations
NCT05662540
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
NARecruiting
40 participants
Started: May 26, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05683223
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
NARecruiting
240 participants
Started: May 26, 2023 · Completed: Jun 30, 2027
1 condition4 sponsors1 location
NCT06028724
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
N/ARecruiting
782 participants
Started: May 26, 2023 · Completed: May 31, 2030
14 conditions1 sponsor1 location
NCT05326477
Predictors of Behavioral Obesity Treatment Outcomes
NARecruiting
230 participants
Started: May 26, 2023 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT05724745
Evaluation of 3D Magnetic Resonance Spirometry: Comparison with Spirometry in Healthy Subjects and Patients with Respiratory Pathologies (asthma, COPD, Bilateral Lung Transplant)
NARecruiting
240 participants
Started: May 26, 2023 · Completed: May 31, 2028
3 conditions1 sponsor1 location
NCT06390696
Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis
NARecruiting
80 participants
Started: May 26, 2023 · Completed: Sep 30, 2027
4 conditions2 sponsors2 locations
NCT05866029
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NARecruiting
2,478 participants
Started: May 26, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor58 locations
NCT05785624
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease
PHASE2Recruiting
320 participants
Started: May 26, 2023 · Completed: Aug 10, 2027
2 conditions1 sponsor117 locations